PMC:7402624 / 4485-4677 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"103","span":{"begin":48,"end":56},"obj":"Species"},{"id":"105","span":{"begin":39,"end":47},"obj":"Disease"}],"attributes":[{"id":"A103","pred":"tao:has_database_id","subj":"103","obj":"Tax:9606"},{"id":"A105","pred":"tao:has_database_id","subj":"105","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"od. Because potential therapeutics for COVID-19 patients include approaches to inhibit, activate, or otherwise modulate immune function, it is essential to define the immune response character"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T32","span":{"begin":39,"end":47},"obj":"Disease"}],"attributes":[{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"od. Because potential therapeutics for COVID-19 patients include approaches to inhibit, activate, or otherwise modulate immune function, it is essential to define the immune response character"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T48","span":{"begin":88,"end":96},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"od. Because potential therapeutics for COVID-19 patients include approaches to inhibit, activate, or otherwise modulate immune function, it is essential to define the immune response character"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T24","span":{"begin":167,"end":182},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"od. Because potential therapeutics for COVID-19 patients include approaches to inhibit, activate, or otherwise modulate immune function, it is essential to define the immune response character"}